Vor Biopharma Inc. (VOR) Tops Q1 EPS by 11c

Vor Biopharma Inc. (NASDAQ: VOR) reported Q1 EPS of ($0.43), $0.11 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Getty Realty (GTY) Reiterated at Market Outperform by Citizens on Investment Volumes
• Ennis (EBF) Misses Q2 EPS by 2c